Varicose Veins Clinical Trial
Official title:
Microwave Venous Ablation in Comparison to Radiofrequency Ablation, Laser Ablation and Surgical Ligation in Management of Great Saphenous Vein Incompetence
The authors will aim to compare microwave therapy with other lines of management radio-frequency ablation, Laser ablation and surgical ligation; regarding time to recurrence rate, ulcer-free time, and health-related quality of life. In a randomized controlled study,The study will be conducted at the department of vascular surgery in Mansoura university hospitals
INTRODUCTION:
Chronic venous disease (CVD) is one of the most common pathologies in the general population
of adults in both industrialized and developing countries.1 the most severe form of CVD is
venous ulceration with an overall prevalence of about 1 % in the adult population, which
increases with age and is more common in women and obese patients. Venous ulcers
significantly impair quality of life, and their treatment places a heavy financial burden
upon healthcare systems. Varicose veins (VVS) is a common disease in adults, and VVS without
skin changes are present in about 20% of the population, while active ulcers are found in
0.5%. The traditional surgical treatment of VVS is high ligation of the great saphenous vein
(GSV), axial stripping and phlebotomy, but the postoperative clinical recurrence is as high
as 60%.
Recently, minimally invasive techniques, such as endovenous laser ablation (EVLA) and
radiofrequency ablation (RFA), have become widely used for the treatment of VVS. Several
reports have shown Several reports have shown that endovenous techniques are as effective as
traditional procedures.
Endovenous Microwave Ablation (EMA) for the treatment of VVS differs from the other
endovenous methods, and no specific dose regime has been established for this system. Thus,
it is unclear if EMA is more or less effective than conventional surgery, or whether it has
any additional benefits. In this study, we compared the clinical outcome of high ligation and
stripping (HLS) with EMA. Postoperative quality of life (QoL) analysis was assessed using the
Aberdeen Varicose Vein Questionnaire (AVVQ) and Venous Clinical Severity Score (VCSS).
Aim of the work: Aimed to compare microwave therapy with other lines of management
radiofrequency ablation, Laser ablation and surgical ligation; regarding time to recurrence
rate, ulcer-free time, and health-related quality of life.
Patients and methods Study location: The study will be conducted at the department of
vascular surgery in Mansoura university hospitals Type of study: Randomized controlled
Prospective study Study duration: 2 years: 2019-2021 Sample size: It will include all
patients presented to our department fulfilling the inclusion criteria.
Study population: The study will be conducted in patients with Incompetent Great saphenous
vein
Inclusion criteria:
• Primary symptomatic VVS (CEAP, C3eC6), sapheno-femoral junction (SFJ) incompetence, GSV
reflux from the groin to below the knee
Exclusion criteria:
• Exclusion criteria included a history of venous surgery, suspected or proven deep venous
thrombosis, reflux of deep veins to distal limb, duplication of GSV, and patients' refusal to
participate in the trial.
Consent: Patients after signing informed consent that possible complication from the
procedure ought to happen and what are the alternatives.
Data collection: The demographics, Symptoms and preoperative clinical data will be collected
History Data: included patient's demographics, underlying medical conditions, any previous
associated morbidity.
Examination: Venous examinations. Laboratory: Blood picture, Blood sugar level, Kidney
functions, Liver functions and Coagulation profile.
Imaging: Duplex US Method of Randomization: Computer based Therapies Surgical group.
Conventional surgical procedures will carried out through a 3-4 cm incision in the groin. The
trunk of GSV and the tributaries will be ligated and divided. The GSV will be removed using a
pin-stripper, and all varices and incompetent perforators will be removed by phlebectomy.
Microwave group. The microwave treating wire (Microwave Intracavity Coagulation System;
Shanghai Medical Electronics, Shanghai, China) will be inserted into the GSV until it reached
the medial aspect of ankle, guided by a light that illuminated the tip of the wire. Then, GSV
will be ablated using pulse mode at 20-30 W. The treating wire will be withdrawn at 2-4 mm/s,
with the ablation time lasting 2 s (energy delivery to the GSV was estimated at around 80
J/cm); the treatment parameters will be based on a previous report. Tumescence will be used
in all patients with 0.9% saline containing 20 mL 2% lidocaine with 1: 200,000 adrenaline and
20 mL 0.5% levobupivacaine in 1 L 0.9% saline.
Laser ablation group: Endovenous Laser Ablation (EVLA) uses a laser Fiber, which is inserted
into the abnormal vein via a small skin puncture.using 1470 nm laser and a "radial" fiber for
less discomfort. Two weeks later the "branch vessels" have reduced in size Radiofrequency
ablation group: inserts a small catheter into the diseased vein through a small incision,
using ultrasound guidance for an accurate and live view. Consistent and uniform heat is
delivered to contract the collagen in the vein walls, causing them to collapse and close.
After the vein is closed the treated vein is gradually absorbed into surrounding tissue
Follow up
Criteria for technical success will be:
1. Closed or absent GSV with lack of flow
2. A re-canalized GSV or treatment failure will be defined as an open segment of the
treated vein segment of >10 cm in length.
3. All patients will be followed as outpatients up at 1, 3, 6, 12, and 24 months after
surgery.
4. The operation time, number of incisions, intraoperative blood loss (determined by the
swabs weighed pre and postoperatively)
5. Recurrence of varicosities will be recorded, as well as any complications.
The criteria for assessment:
1. Ecchymosis was confirmed 72 h after operation when the lividity and congestion area was
>1 cm2 in the affected limbs.
2. Skin burns were identified 72 h after operation when the skin was red and oedematous
according to the criteria for burns.
3. Recurrence was defined by both duplex ultrasound and the clinical examination. A
varicose vein that had not been observed before or previously been marked by the patient
on the AVVQ form was considered to be a recurrent varicose vein (owing to
neo-vascularization or dilation of pre-existing veins).
4. Sensory impairment (numbness) that occurred around incisions was recorded based on the
patient's history and physical examination.
QoL assessment The diseased relation effect on QoL was determined using the AVVQ (Chinese
version), which assessed the specific effect on QoL and was scored from 0 (no effect of VVS
on QoL) to a theoretical maximum of 100.8 The VCSS (Chinese version) was also completed (for
the VCSS, 0 represents no significant venous disease and 30 is the maximum score), which is a
valid sensitive and responsive measure of the severity of VVS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02441881 -
Trial of Radiofrequency Thermo-ablation Treatments of Great Saphenous Varicose Veins (3-RF Study)
|
N/A | |
Completed |
NCT03283800 -
Copper Impact on Venous Insufficiency and Lipodermatosclerosis
|
N/A | |
Recruiting |
NCT02676908 -
Optimum Duration of Compression Stockings After Endovenous Varicose Vein Surgery
|
N/A | |
Withdrawn |
NCT01426035 -
Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate Cream In The Superficial Varicose Veins Treatment
|
Phase 3 | |
Withdrawn |
NCT01203397 -
Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins Treatment
|
Phase 3 | |
Recruiting |
NCT02054325 -
Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins
|
Phase 4 | |
Withdrawn |
NCT03601572 -
Hypnoanalgesia in Surgical and Endovenous Treatment of Varicosis
|
||
Completed |
NCT04933591 -
Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood
|
N/A | |
Active, not recruiting |
NCT02397226 -
Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery
|
N/A | |
Withdrawn |
NCT02936271 -
Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting
|
N/A | |
Terminated |
NCT02557542 -
Pilot RCT Evaluating a One Stop Vein Clinic
|
N/A | |
Completed |
NCT00758420 -
Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT00841178 -
Endovenous Laser Therapy (EVLT) for Sapheno-Popliteal Incompetence and Short Saphenous Vein (SSV) Reflux: A RCT
|
N/A | |
Not yet recruiting |
NCT05508581 -
Microwaves Ablation of Varicose Veins
|
N/A | |
Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
Active, not recruiting |
NCT04339075 -
Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore
|
||
Completed |
NCT03392753 -
Mechanochemical Ablation Compared to Cyanoacrylate Adhesive
|
N/A | |
Recruiting |
NCT04146168 -
Lake Washington Vascular VenaSeal™ Post-Market Evaluation
|
||
Recruiting |
NCT02304146 -
Long-term Ultrasound Guided Foam Sclerotherapy Versus Classical Surgical Stripping Study
|
N/A | |
Completed |
NCT01231373 -
Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
|
Phase 3 |